Glucagon-Like Peptide-1 Infusion Must Be Maintained for 24 h/day to Obtain Acceptable Glycemia in Type 2 Diabetic Patients Who Are Poorly Controlled on Sulphonylurea Treatment
Year: 2001
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Diabetes Care
Authors: Jens Larsen, Birgitte Hylleberg, Kevin Ng, Peter Damsbo
Institutions: Novo Nordisk (Denmark), University of Miami
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2073996229
